Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Relative contribution of basal and postprandial hyperglycaemia stratified by HbA1c categories before and after treatment intensification with dulaglutide
Published September 17, 2025
Meanwhile, a potential tirzepatide competitor efruxifermin from Akero showed promising results in a phase 2a trial for NASH
Without insurance coverage for GLP-1 medications, known by brand names Fundayo, Ozempic, Wegovy, Mounjaro, or Zepbound, individuals could spend anywhere from $900 to $1,300 a month
US$ 24.64
US$ 27.69
US$ 26.14
US$ 24.11
US$ 29.53
US$ 27.62
US$ 26.53
US$ 20.21
US$ 26.80
US$ 24.59
US$ 24.40
US$ 24.67
US$ 20.65
US$ 24.30
US$ 27.47
US$ 25.81
US$ 29.89
